Picture of Vanda Pharmaceuticals logo

VNDA — Vanda Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

U.S. STOCKS ON THE MOVE-Nike, silver and gold miners, Vanda Pharma, Tesla

U.S. stock index futures moved lower on the last trading day of 2025, but were set to wrap up a roller-coaster year characterized by uncertainty over President Donald Trump's tariffs and unrivalled euphoria around AI with robust gains.  .N

** Nike NKE.N

BUZZ- Up after CEO Hill buys stock worth $1 mln nL6N3Y106V

** Endeavour Silver EXK.N

** Silvercorp Metals SVM.N

** Coeur Mining CDE.N

** Abrdn Physical Silver Shares ETF SIVR.P

** iShares Silver Trust SLV.P:

BUZZ- Silver miners gain in 2025 driven by metal's historic rally nL6N3Y1073

** Newmont NEM.N

** Gold Fields GFI.N

** Harmony Gold HMY.N

** Sibanye Stillwater SBSW.N

** Agnico Eagle Mines AEM.N

** Kinross Gold KGC.N

BUZZ- Gold miners surge in 2025 as bullion heads for biggest annual gain since 1979 nL4N3Y10CL

** Vanda Pharmaceuticals VNDA.O

BUZZ- Jumps after US FDA approves motion sickness drug nL4N3Y10D9

** Rocket Lab RKLB.O

** Planet Labs PL.N

** AST SpaceMobile ASTS.O

** Globalstar GSAT.O

** Procure Space UFO.O

BUZZ- Space stocks surge on growing commercialization, investments nL6N3Y107L

** Pfizer PFE.N

** Moderna MRNA.O

** Novavax NVAX.O

** BioNTech BNTX.O

BUZZ- Vaccine makers end the year in red nL4N3Y10EE

** JPMorgan Chase JPM.N

** Goldman Sachs GS.N

** Morgan Stanley MS.N

** Bank of America BAC.N

** Wells Fargo WFC.N

** Citigroup C.N

BUZZ- A 'new era' ahead? Top US banks ride a blockbuster year into 2026 nL4N3Y10B8

** CVS CVS.N

** UnitedHealth UNH.N

** Elevance ELV.N

** Centene CNC.N

** Molina Healthcare MOH.N

** Humana HUM.N

** Cigna CI.N

BUZZ- CVS set to end 2025 higher, UnitedHealth set for yearly fall nL4N3Y00PB

** Tesla TSLA.O

BUZZ- Set for slowest rise in three years, sagging demand pressures stock nL6N3Y00DO

 (Compiled by Arnav Mishra in Bengaluru)

 ((Arnav.Mishra@thomsonreuters.com;))

Recent news on Vanda Pharmaceuticals

See all news